Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study.
about
Electrophoretic particle guidance significantly enhances olfactory drug delivery: a feasibility studyChemical composition of Nigella sativa Linn: Part 2 Recent advancesFormulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties, In vitro Release, and Antiproliferative Activity of Thymoquinone Drug.Nose-To-Brain Delivery of PLGA-Diazepam NanoparticlesThe nasal delivery of nanoencapsulated statins - an approach for brain deliveryAdvances in preparation and characterization of chitosan nanoparticles for therapeutics.Nanoneurotherapeutics approach intended for direct nose to brain delivery.Improving drug delivery technology for treating neurodegenerative diseases.Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management.Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration.Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.Improving intranasal delivery of neurological nanomedicine to the olfactory region using magnetophoretic guidance of microsphere carriersModeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols.Formulation, characterization and antimicrobial properties of black cumin essential oil nanoemulsions stabilized by OSA starch.Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.Evaluation of brain targeting in rats of Salvianolic acid B nasal delivery by the microdialysis technique.Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.Optimization of magnetophoretic-guided drug delivery to the olfactory region in a human nose model.Nano-ropinirole for the management of Parkinsonism: blood-brain pharmacokinetics and carrier localization.The effect of safranal loaded mucoadhesive nanoemulsion on oxidative stress markers in cerebral ischemia.A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson's diseaseProtective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases
P2860
Q28539362-E5C9FA8D-3C11-420F-B1F4-8FA9C90B3A7BQ28833205-5D44106D-0383-4186-BBAF-A2F6173EE1E3Q34383339-26095AFE-3298-41D1-B9F4-2D1254D18D2EQ36294635-DA78D7A5-4BDC-4587-863F-D58066975455Q36360517-C2F3FABF-09EF-47FC-8F58-486CEE4DD5DBQ37496394-2454CD3B-A797-4CC9-A63E-EA06A33F3E39Q38241277-8020AF09-5E77-4570-B9B9-379B55E61ECCQ38522125-E6536A59-37EB-4635-AD42-CE513AB97539Q38769989-B21999C4-2BB6-4D70-99E0-BE67D01D3F69Q38899961-A83810CD-0AF3-40BF-B199-D64484CA3873Q39131775-87B7EAEC-072C-472D-B44A-AEA751668B9BQ40777740-ECFB65FA-B1A5-4DAD-B4B7-D3C5F79BCB05Q41824062-8975F108-DFE7-44B5-AC27-154468BB80DFQ46155123-2FE11305-DA36-480B-B0BD-0D55F0F521FDQ47858462-1CF216C3-A7C9-4DEA-91BE-BAC1EC689C2AQ47893114-DA33EE6D-8ABF-44D5-8810-A47718A3E02CQ48020930-C8E7E314-7413-469D-8B61-223923D87674Q48130937-80520EC6-7AC8-4ED2-91F7-750085BC22A4Q48131388-61935322-288A-4C79-A701-32BE143DCFCAQ48187795-FFFB5D9D-D59B-4974-92E6-18A510572207Q48522912-F1BE88B3-4AAA-46A0-AAFE-1DFB1416ADC1Q48818624-6C233D48-CD00-4BC3-AF74-FCA02F9646F7Q52654049-E851530A-F56E-4A79-AA3A-FFB5CB3F89F4Q57369531-06303CB9-DDD5-463D-9466-2F2C96FBA805Q58696844-57B9568D-7906-451E-B58C-D0AB95E09316
P2860
Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Development and evaluation of ...... a pharmacoscintigraphic study.
@ast
Development and evaluation of ...... a pharmacoscintigraphic study.
@en
Development and evaluation of ...... a pharmacoscintigraphic study.
@nl
type
label
Development and evaluation of ...... a pharmacoscintigraphic study.
@ast
Development and evaluation of ...... a pharmacoscintigraphic study.
@en
Development and evaluation of ...... a pharmacoscintigraphic study.
@nl
prefLabel
Development and evaluation of ...... a pharmacoscintigraphic study.
@ast
Development and evaluation of ...... a pharmacoscintigraphic study.
@en
Development and evaluation of ...... a pharmacoscintigraphic study.
@nl
P2093
P2860
P356
P1476
Development and evaluation of ...... a pharmacoscintigraphic study
@en
P2093
Aseem Bhatnagar
Fakhrul Islam
Gulam Mustafa
Manish Kumar
Sanjar Alam
Zeenat I Khan
P2860
P304
P356
10.2147/IJN.S35329
P407
P577
2012-11-09T00:00:00Z